Announcement of Resolutions of the 8th Meeting of the 9th Board of Directors of Hengrui Pharmaceutical
Hengrui Pharmaceutical's Announcement on Obtaining Approval Notice for Drug Clinical Trials
Hengrui Pharmaceutical's Announcement on the Company's Drug Obtaining Fast Track Qualification from the US FDA
Hengrui Pharmaceutical's Announcement on Holding Results Briefings for the First Quarter of 2023 and 2024
Announcement of Resolutions of the 7th Meeting of the 9th Board of Directors of Hengrui Pharmaceutical
Hengrui Pharmaceutical Independent Director Work System
Hengrui Pharmaceutical 2023 Audit Report
Special note on the 2023 non-operating capital occupation and other related capital transactions of Jiangsu Hengrui Pharmaceutical Co., Ltd.
Hengrui Pharmaceutical 2023 Independent Director Debriefing Report (Zeng Qingsheng)
Hengrui Pharmaceutical 2023 Internal Control Audit Report
Hengrui Pharmaceutical 2023 Independent Director Debriefing Report (Dong Jiahong)
Hengrui Pharmaceutical 2023 Independent Director Debriefing Report (Sun Jinyun)
Hengrui Pharmaceutical\'s 2023 Accounting Firm Performance Assessment Report
Hengrui Pharmaceutical\'s announcement on the change of accounting firm
Announcement of Resolutions of the 6th Meeting of the 9th Board of Supervisors of Hengrui Pharmaceutical
Hengrui Pharmaceutical\'s Announcement on Providing Home Purchase Loans for Employees
Hengrui Pharmaceutical\'s Announcement on Obtaining Approval Notice for Drug Clinical Trials
Hengrui Pharmaceutical's Announcement on Obtaining Approval Notice for Drug Clinical Trials
Hengrui Pharmaceutical's Announcement on Obtaining Approval Notice for Drug Clinical Trials
Hengrui Pharmaceutical's Announcement on Obtaining Approval Notice for Drug Clinical Trials
No Data